These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21864535)

  • 21. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of oligodendrocytes in chronic relapsing experimental autoimmune encephalomyelitis.
    Moore GR; Traugott U; Raine CS
    J Neurol Sci; 1984 Aug; 65(2):137-45. PubMed ID: 6481396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO
    Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
    J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a benzothiazole-based LRRK2 inhibitor in oligodendrocyte precursor cells and in a murine model of multiple sclerosis.
    Benítez-Fernández R; Josa-Prado F; Sánchez E; Lao Y; García-Rubia A; Cumella J; Martínez A; Palomo V; de Castro F
    CNS Neurosci Ther; 2024 Jan; 30(1):e14552. PubMed ID: 38287523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
    Motavaf M; Sadeghizadeh M; Javan M
    Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remyelination therapy for multiple sclerosis.
    Keough MB; Yong VW
    Neurotherapeutics; 2013 Jan; 10(1):44-54. PubMed ID: 23070731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple Sclerosis: Basic and Clinical.
    Buzzard K; Chan WH; Kilpatrick T; Murray S
    Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
    Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
    J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
    Rone MB; Cui QL; Fang J; Wang LC; Zhang J; Khan D; Bedard M; Almazan G; Ludwin SK; Jones R; Kennedy TE; Antel JP
    J Neurosci; 2016 Apr; 36(17):4698-707. PubMed ID: 27122029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.
    Harrington EP; Zhao C; Fancy SP; Kaing S; Franklin RJ; Rowitch DH
    Ann Neurol; 2010 Nov; 68(5):703-16. PubMed ID: 20853437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of oligodendrocyte generation in multiple sclerosis.
    Yeung MSY; Djelloul M; Steiner E; Bernard S; Salehpour M; Possnert G; Brundin L; Frisén J
    Nature; 2019 Feb; 566(7745):538-542. PubMed ID: 30675058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.
    Murray PD; McGavern DB; Sathornsumetee S; Rodriguez M
    Brain; 2001 Jul; 124(Pt 7):1403-16. PubMed ID: 11408335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelin repair strategies: a cellular view.
    Gallo V; Armstrong RC
    Curr Opin Neurol; 2008 Jun; 21(3):278-83. PubMed ID: 18451710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortical remyelination: a new target for repair therapies in multiple sclerosis.
    Chang A; Staugaitis SM; Dutta R; Batt CE; Easley KE; Chomyk AM; Yong VW; Fox RJ; Kidd GJ; Trapp BD
    Ann Neurol; 2012 Dec; 72(6):918-26. PubMed ID: 23076662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remyelination in multiple sclerosis.
    Piaton G; Williams A; Seilhean D; Lubetzki C
    Prog Brain Res; 2009; 175():453-64. PubMed ID: 19660673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.
    Miller RH; Fyffe-Maricich SL
    Dis Model Mech; 2010; 3(9-10):535-9. PubMed ID: 20647413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model.
    Romanelli E; Merkler D; Mezydlo A; Weil MT; Weber MS; Nikić I; Potz S; Meinl E; Matznick FE; Kreutzfeldt M; Ghanem A; Conzelmann KK; Metz I; Brück W; Routh M; Simons M; Bishop D; Misgeld T; Kerschensteiner M
    Nat Commun; 2016 Nov; 7():13275. PubMed ID: 27848954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis.
    Lucchinetti CF; Brück W; Rodriguez M; Lassmann H
    Brain Pathol; 1996 Jul; 6(3):259-74. PubMed ID: 8864283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are electrophysiological and oligodendrocyte alterations an element in the development of multiple sclerosis at the same time as or before the immune response?
    Ortiz GG; Mireles-Ramírez MA; Pacheco-Moisés FP; Ramírez-Jirano LJ; Bitzer-Quintero OK; Delgado-Lara DLC; Flores-Alvarado LJ; Mora-Navarro MA; Huerta M; Torres-Mendoza BMG
    Int J Neurosci; 2021 Dec; 131(12):1221-1230. PubMed ID: 32571126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.